Scope Fluidics Spolka Akcyjna (WAR:SCP) Cyclically Adjusted Revenue per Share: zł0.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCP Scope Fluidics Spolka Akcyjna WAR:SCP
50 GF Score
Price zł120.00
GF Value zł128.63
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Cyclically Adjusted Revenue per Share?

Scope Fluidics Spolka Akcyjna WAR:SCP -0.17% 50 Cyclically Adjusted Revenue per Share is zł0.16 as of Mar. 2026. GuruFocus rates WAR:SCP with a GF Score™ of 50/100 and a GF Value™ of zł128.63 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Scope Fluidics Spolka Akcyjna's adjusted revenue per share for the three months ended in Mar. 2026 was zł0.009. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł0.16 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-19), Scope Fluidics Spolka Akcyjna's current stock price is zł120.00. Scope Fluidics Spolka Akcyjna's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł0.16. Scope Fluidics Spolka Akcyjna's Cyclically Adjusted PS Ratio of today is 750.00.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Scope Fluidics Spolka Akcyjna was 878.75. The lowest was 728.75. And the median was 765.00.


Scope Fluidics Spolka Akcyjna  (WAR:SCP) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Scope Fluidics Spolka Akcyjna's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=120.00/0.16
=750.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 10 years, the highest Cyclically Adjusted PS Ratio of Scope Fluidics Spolka Akcyjna was 878.75. The lowest was 728.75. And the median was 765.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Scope Fluidics Spolka Akcyjna Cyclically Adjusted Revenue per Share Related Terms


Scope Fluidics Spolka Akcyjna Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Cyclically Adjusted Revenue per Share Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.16

WAR:SCP vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Cyclically Adjusted PS Ratio falls into.


WAR:SCP
50GF Score
Scope Fluidics Spolka Akcyjna WAR:SCP
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Scope Fluidics Spolka Akcyjna's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.009/163.0700*163.0700
=0.009

Current CPI (Mar. 2026) = 163.0700.

Scope Fluidics Spolka Akcyjna Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.056 99.552 0.092
201609 0.002 99.064 0.003
201612 0.000 100.366 0.000
201703 0.000 101.018 0.000
201706 0.001 101.180 0.002
201709 0.000 101.343 0.000
201712 0.000 102.564 0.000
201803 0.000 102.564 0.000
201806 0.000 103.378 0.000
201809 0.000 103.378 0.000
201812 0.000 103.785 0.000
201903 0.000 104.274 0.000
201906 0.000 105.983 0.000
201909 0.000 105.983 0.000
201912 0.000 107.123 0.000
202003 0.000 109.076 0.000
202006 0.000 109.402 0.000
202009 0.000 109.320 0.000
202012 0.000 109.565 0.000
202103 0.000 112.658 0.000
202106 0.000 113.960 0.000
202109 0.000 115.588 0.000
202112 0.000 119.088 0.000
202203 0.000 125.031 0.000
202206 0.000 131.705 0.000
202209 0.000 135.531 0.000
202212 0.148 139.113 0.173
202303 0.169 145.950 0.189
202306 0.016 147.009 0.018
202309 0.001 146.113 0.001
202312 0.003 147.741 0.003
202403 0.014 149.044 0.015
202406 0.018 150.997 0.019
202409 0.009 153.439 0.010
202412 0.007 154.660 0.007
202503 0.008 157.021 0.008
202506 0.240 157.509 0.248
202509 0.008 158.000 0.008
202512 -0.133 158.320 -0.137
202603 0.009 163.070 0.009

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł0.16 mean?
Scope Fluidics Spolka Akcyjna (WAR:SCP) has a Cyclically Adjusted Revenue per Share of zł0.16 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Scope Fluidics Spolka Akcyjna and its competitors.
Is Scope Fluidics Spolka Akcyjna's Cyclically Adjusted Revenue per Share too high?
Scope Fluidics Spolka Akcyjna's current Cyclically Adjusted Revenue per Share is zł0.16. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Scope Fluidics Spolka Akcyjna's Cyclically Adjusted Revenue per Share of zł0.16 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Cyclically Adjusted Revenue per Share is zł0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna (WAR:SCP) is currently considered Fairly Valued. The stock's GF Value™ is zł128.63, compared to a current price of zł120.00 — trading 6.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł0.16. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (WAR:SCP), the current Cyclically Adjusted Revenue per Share is zł0.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (WAR:SCP) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of zł120.00 is trading 6.7% below its estimated GF Value™ of zł128.63. GuruFocus considers Scope Fluidics Spolka Akcyjna to be Fairly Valued.

Key valuation signals for WAR:SCP:

  • Cyclically Adjusted Revenue per Share: zł0.16
  • GF Value™: zł128.63 vs. price of zł120.00 (6.7% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the WAR:SCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges S84:Germany
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
50GF Score

Get the complete analysis for WAR:SCP

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł120.00
Price
zł128.63
GF Value